WeVote
Log In

Bill

Bill

SF 2164

Commercial and industrial products exemption from certain PFAS restrictions provision and PFAS reporting requirements modifications provision

2025-2026 Regular Session Introduced by Justin Eichorn and 1 co-sponsor

Minnesota bill SF 2164 exempts commercial-industrial products from PFAS bans and weakens PFAS reporting requirements, potentially reintroducing restricted chemicals into supply chains.

Referred to Environment, Climate, and Legacy
#commerceandcommercedepartment #environment
0
WeVote Research Nonpartisan
Bill Summary · SF 2164

Legislative bill overview

SF 2164 modifies Minnesota's PFAS (per- and polyfluoroalkyl substances) restrictions by exempting certain commercial and industrial products from existing bans and altering reporting requirements for PFAS-containing materials. The bill narrows the scope of PFAS restrictions that were previously enacted to protect public health and the environment from these persistent "forever chemicals."

Why is this important

PFAS chemicals accumulate in the environment and human bodies, linked to health issues including liver damage, immune system effects, and developmental problems. Minnesota has been a leader in PFAS restrictions, so this bill represents a significant policy reversal that could reintroduce regulated chemicals into commercial supply chains and reduce transparency about their use.

Potential points of contention

  • Industry vs. health advocates: Manufacturers argue exemptions reduce compliance costs and maintain competitiveness, while environmental and public health groups contend weakening restrictions undermines protection from documented health harms
  • Scientific uncertainty about alternatives: While exemptions may be justified if safer substitutes aren't available for specific industrial applications, opponents question whether genuine necessity exists versus mere convenience
  • Reporting transparency: Modifying reporting requirements could obscure how widely PFAS chemicals remain in use, making it harder for regulators and the public to track exposure sources and health risks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.